Machine Learning

Systecon's new Opus Suite+ integrates AI and cloud tech, unifying its core tools to optimize readiness for the F-35, GCAP, and critical industries.

METABORA's new platform moves beyond play-to-earn with tailored quests and instant games, aiming to boost BORA token utility in the Web3 ecosystem.

The neurotech pioneer reports strong sales for its spinal cord injury therapy, secures key FDA approvals, and plans for major US stock market entry.

In a world of fragile connections, Tata Communications' new AI-powered platform promises to automatically fix network disruptions in seconds. Here's how.

Toshiba begins sampling massive 30-34TB hard drives, using advanced tech to help hyperscale data centers cope with the explosive growth of AI and cloud data.

Sangamo pushes a promising Fabry disease therapy toward the FDA while a cash crunch forces a strategic pivot to brain-targeting neurological cures.

A new platform from the founders of PriceGrabber.com uses a multi-AI system to score scripts, aiming to revolutionize the $300B entertainment industry.

In a strategic move to dominate the future of warfare, Red Cat Holdings has acquired Apium Swarm Robotics, deepening its role in a new defense tech race.

With a new manufacturing chief from Amazon Robotics, the Houston startup is scaling production of humanoids to tackle critical labor shortages in heavy industry.

With a new strategic investment from Viking Global Investors, Valstone is set to accelerate its acquisition spree and AI development in critical industries.

A new AI trading bot, MoneyFlare, claims to make crypto investing effortless. But can a 'zero learning curve' platform truly tame a notoriously volatile market?

A new book details a Korean Zen master's dialogues with an AI, using ancient meditation to explore machine consciousness. Is this a spiritual breakthrough?

A student-founded AI startup partners with a real estate giant, embedding its founders to deploy predictive migration tech across a $2.8 billion portfolio.

With improved financials and progress on therapies for cannabis use disorder and Down syndrome, the French biotech charts a confident course for the future.

A massive new dataset integrating brain scans, wearables, and biomarkers is now open to researchers, promising a new era for bipolar disorder treatment.

Formerly Arcus Power, Arcobi debuts a unified platform using AI and 25 years of data to help businesses navigate the increasingly complex energy grid.

Formerly Asha Therapeutics, the biotech rebrands with top talent and an AI platform that designs novel medicines from scratch for humanity's toughest diseases.

The new Identity Command Center from KeyData Cyber offers security leaders real-time control, shifting identity management from fragmented projects to a unified program.

Deepvein Mining unveils DeepSight, an AI-driven system using drones and robot dogs to find minerals faster, cheaper, and more safely than ever before.

A new AI test promises to tell patients their personal benefit from chemotherapy, aiming to end decades of one-size-fits-all treatment decisions.